ImmunoScape

Singapore, Singapore · Founded 2016 · Privately Held (backing)

Developer of an immune profiling system and analytical tools designed to support immunotherapy clinical development. ImmunoScape is based in Singapore, Singapore and was founded in 2016. Its last reported valuation was $80.8 million in Jun 2025. It has raised $60.4 million.

Last reported valuation

$80.8M

Oct 2026

Priced at

—

Total raised

$60.4M

Last round

—

How much has ImmunoScape raised?

$60.4Macross 0 recorded rounds

Free account

More of ImmunoScape with a free account

·Watch ImmunoScape: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

ImmunoScape investors

9 investors are on record for ImmunoScape, including EDBI, Johnson & Johnson Innovation - JLABS, The University of Tokyo Edge Capital and Leonardo DiCaprio.

For fundraisers

Raising for a company like ImmunoScape?

9 investors have backed ImmunoScape.

See all 9 investors →

Frequently asked about ImmunoScape

How much has ImmunoScape raised?: ImmunoScape has raised $60.4M in total across 0 recorded funding rounds.